Genetic loci associated with nonobstructive coronary artery disease in Caucasian women

Liming Weng, Kent D. Taylor, Yii Der Ida Chen, George Sopko, Sheryl F. Kelsey, C. Noel Bairey Merz, Carl J. Pepine, Virginia M Miller, Jerome I. Rotter, Martha Gulati, Mark O. Goodarzi, Rhonda M. Cooper-DeHoff

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Nonobstructive coronary artery disease (CAD) in women is associated with adverse cardiovascular (CV) outcomes; however, information regarding genetic variants that predispose women to nonobstructive CAD is lacking. Women from the Women's Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) Study were genotyped with the Cardio-MetaboChip. WISE enrolled women with symptoms and signs of ischemia referred for coronary angiography; WTH enrolled asymptomatic, community-based women without heart disease. Analyses were conducted with a case (WISE) - control (WTH) design and multivariate logistic regression models to investigate genetic variation associated with likelihood of nonobstructive CAD. One genetic marker, single nucleotide polymorphism (SNP) rs2301753 on chromosome 6 in RNF39, achieved chip-wide significance for nonobstructive CAD (P <9.5 × 10−7). After adjusting for baseline characteristics, we found no variants achieved chip-wide significance. However, SNP rs2301753 on chromosome 6 in RNF39 was associated with reduced likelihood of nonobstructive CAD [odds ratio (OR) 0.42 and 95% confidence interval (CI) of 0.29 to 0.68], at a nominal level of P= 5.6 × 10−6, while SNP rs12818945 in the ATP2B1 locus on chromosome 12 was associated with increased odds for nonobstructive CAD (OR 2.38 and 95% CI of 1.63 to 3.45) and nominal P = 5.8 × 10−6. The functions of RNF39and ATP2B1 raise the possibility that genes involved in cardio-dysfunction may contribute to nonobstructive CAD in Caucasian women and may provide insights into novel approaches for therapy and prevention. If replicated, incorporation of these genetic variants into diagnostic evaluation may identify women at high risk for nonobstructive CAD.

Original languageEnglish (US)
Pages (from-to)12-20
Number of pages9
JournalPhysiological Genomics
Volume48
Issue number1
DOIs
StatePublished - Jan 1 2016

Fingerprint

Genetic Loci
Coronary Artery Disease
Ischemia
Single Nucleotide Polymorphism
Chromosomes, Human, Pair 6
Logistic Models
Odds Ratio
Confidence Intervals
Chromosomes, Human, Pair 12
Coronary Angiography
Genetic Markers
Signs and Symptoms
Heart Diseases

Keywords

  • Cardio-metabochip
  • Genetics
  • Nonobstructive coronary artery disease
  • Sex

ASJC Scopus subject areas

  • Physiology
  • Genetics

Cite this

Weng, L., Taylor, K. D., Chen, Y. D. I., Sopko, G., Kelsey, S. F., Bairey Merz, C. N., ... Cooper-DeHoff, R. M. (2016). Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. Physiological Genomics, 48(1), 12-20. https://doi.org/10.1152/physiolgenomics.00067.2015

Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. / Weng, Liming; Taylor, Kent D.; Chen, Yii Der Ida; Sopko, George; Kelsey, Sheryl F.; Bairey Merz, C. Noel; Pepine, Carl J.; Miller, Virginia M; Rotter, Jerome I.; Gulati, Martha; Goodarzi, Mark O.; Cooper-DeHoff, Rhonda M.

In: Physiological Genomics, Vol. 48, No. 1, 01.01.2016, p. 12-20.

Research output: Contribution to journalArticle

Weng, L, Taylor, KD, Chen, YDI, Sopko, G, Kelsey, SF, Bairey Merz, CN, Pepine, CJ, Miller, VM, Rotter, JI, Gulati, M, Goodarzi, MO & Cooper-DeHoff, RM 2016, 'Genetic loci associated with nonobstructive coronary artery disease in Caucasian women', Physiological Genomics, vol. 48, no. 1, pp. 12-20. https://doi.org/10.1152/physiolgenomics.00067.2015
Weng, Liming ; Taylor, Kent D. ; Chen, Yii Der Ida ; Sopko, George ; Kelsey, Sheryl F. ; Bairey Merz, C. Noel ; Pepine, Carl J. ; Miller, Virginia M ; Rotter, Jerome I. ; Gulati, Martha ; Goodarzi, Mark O. ; Cooper-DeHoff, Rhonda M. / Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. In: Physiological Genomics. 2016 ; Vol. 48, No. 1. pp. 12-20.
@article{a20efc5cae6347da916b2706c00c2c00,
title = "Genetic loci associated with nonobstructive coronary artery disease in Caucasian women",
abstract = "Nonobstructive coronary artery disease (CAD) in women is associated with adverse cardiovascular (CV) outcomes; however, information regarding genetic variants that predispose women to nonobstructive CAD is lacking. Women from the Women's Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) Study were genotyped with the Cardio-MetaboChip. WISE enrolled women with symptoms and signs of ischemia referred for coronary angiography; WTH enrolled asymptomatic, community-based women without heart disease. Analyses were conducted with a case (WISE) - control (WTH) design and multivariate logistic regression models to investigate genetic variation associated with likelihood of nonobstructive CAD. One genetic marker, single nucleotide polymorphism (SNP) rs2301753 on chromosome 6 in RNF39, achieved chip-wide significance for nonobstructive CAD (P <9.5 × 10−7). After adjusting for baseline characteristics, we found no variants achieved chip-wide significance. However, SNP rs2301753 on chromosome 6 in RNF39 was associated with reduced likelihood of nonobstructive CAD [odds ratio (OR) 0.42 and 95{\%} confidence interval (CI) of 0.29 to 0.68], at a nominal level of P= 5.6 × 10−6, while SNP rs12818945 in the ATP2B1 locus on chromosome 12 was associated with increased odds for nonobstructive CAD (OR 2.38 and 95{\%} CI of 1.63 to 3.45) and nominal P = 5.8 × 10−6. The functions of RNF39and ATP2B1 raise the possibility that genes involved in cardio-dysfunction may contribute to nonobstructive CAD in Caucasian women and may provide insights into novel approaches for therapy and prevention. If replicated, incorporation of these genetic variants into diagnostic evaluation may identify women at high risk for nonobstructive CAD.",
keywords = "Cardio-metabochip, Genetics, Nonobstructive coronary artery disease, Sex",
author = "Liming Weng and Taylor, {Kent D.} and Chen, {Yii Der Ida} and George Sopko and Kelsey, {Sheryl F.} and {Bairey Merz}, {C. Noel} and Pepine, {Carl J.} and Miller, {Virginia M} and Rotter, {Jerome I.} and Martha Gulati and Goodarzi, {Mark O.} and Cooper-DeHoff, {Rhonda M.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1152/physiolgenomics.00067.2015",
language = "English (US)",
volume = "48",
pages = "12--20",
journal = "Physiological Genomics",
issn = "1094-8341",
publisher = "American Physiological Society",
number = "1",

}

TY - JOUR

T1 - Genetic loci associated with nonobstructive coronary artery disease in Caucasian women

AU - Weng, Liming

AU - Taylor, Kent D.

AU - Chen, Yii Der Ida

AU - Sopko, George

AU - Kelsey, Sheryl F.

AU - Bairey Merz, C. Noel

AU - Pepine, Carl J.

AU - Miller, Virginia M

AU - Rotter, Jerome I.

AU - Gulati, Martha

AU - Goodarzi, Mark O.

AU - Cooper-DeHoff, Rhonda M.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Nonobstructive coronary artery disease (CAD) in women is associated with adverse cardiovascular (CV) outcomes; however, information regarding genetic variants that predispose women to nonobstructive CAD is lacking. Women from the Women's Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) Study were genotyped with the Cardio-MetaboChip. WISE enrolled women with symptoms and signs of ischemia referred for coronary angiography; WTH enrolled asymptomatic, community-based women without heart disease. Analyses were conducted with a case (WISE) - control (WTH) design and multivariate logistic regression models to investigate genetic variation associated with likelihood of nonobstructive CAD. One genetic marker, single nucleotide polymorphism (SNP) rs2301753 on chromosome 6 in RNF39, achieved chip-wide significance for nonobstructive CAD (P <9.5 × 10−7). After adjusting for baseline characteristics, we found no variants achieved chip-wide significance. However, SNP rs2301753 on chromosome 6 in RNF39 was associated with reduced likelihood of nonobstructive CAD [odds ratio (OR) 0.42 and 95% confidence interval (CI) of 0.29 to 0.68], at a nominal level of P= 5.6 × 10−6, while SNP rs12818945 in the ATP2B1 locus on chromosome 12 was associated with increased odds for nonobstructive CAD (OR 2.38 and 95% CI of 1.63 to 3.45) and nominal P = 5.8 × 10−6. The functions of RNF39and ATP2B1 raise the possibility that genes involved in cardio-dysfunction may contribute to nonobstructive CAD in Caucasian women and may provide insights into novel approaches for therapy and prevention. If replicated, incorporation of these genetic variants into diagnostic evaluation may identify women at high risk for nonobstructive CAD.

AB - Nonobstructive coronary artery disease (CAD) in women is associated with adverse cardiovascular (CV) outcomes; however, information regarding genetic variants that predispose women to nonobstructive CAD is lacking. Women from the Women's Ischemia Syndrome Evaluation (WISE) Study and the St. James Women Take Heart (WTH) Study were genotyped with the Cardio-MetaboChip. WISE enrolled women with symptoms and signs of ischemia referred for coronary angiography; WTH enrolled asymptomatic, community-based women without heart disease. Analyses were conducted with a case (WISE) - control (WTH) design and multivariate logistic regression models to investigate genetic variation associated with likelihood of nonobstructive CAD. One genetic marker, single nucleotide polymorphism (SNP) rs2301753 on chromosome 6 in RNF39, achieved chip-wide significance for nonobstructive CAD (P <9.5 × 10−7). After adjusting for baseline characteristics, we found no variants achieved chip-wide significance. However, SNP rs2301753 on chromosome 6 in RNF39 was associated with reduced likelihood of nonobstructive CAD [odds ratio (OR) 0.42 and 95% confidence interval (CI) of 0.29 to 0.68], at a nominal level of P= 5.6 × 10−6, while SNP rs12818945 in the ATP2B1 locus on chromosome 12 was associated with increased odds for nonobstructive CAD (OR 2.38 and 95% CI of 1.63 to 3.45) and nominal P = 5.8 × 10−6. The functions of RNF39and ATP2B1 raise the possibility that genes involved in cardio-dysfunction may contribute to nonobstructive CAD in Caucasian women and may provide insights into novel approaches for therapy and prevention. If replicated, incorporation of these genetic variants into diagnostic evaluation may identify women at high risk for nonobstructive CAD.

KW - Cardio-metabochip

KW - Genetics

KW - Nonobstructive coronary artery disease

KW - Sex

UR - http://www.scopus.com/inward/record.url?scp=84953290625&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953290625&partnerID=8YFLogxK

U2 - 10.1152/physiolgenomics.00067.2015

DO - 10.1152/physiolgenomics.00067.2015

M3 - Article

C2 - 26534935

AN - SCOPUS:84953290625

VL - 48

SP - 12

EP - 20

JO - Physiological Genomics

JF - Physiological Genomics

SN - 1094-8341

IS - 1

ER -